期 |
栏目 |
标题 |
文件 |
卷 81, 编号 9 (2009) |
Editorial |
Treatment of patients with hypertriglyceridemia |
|
卷 82, 编号 4 (2010) |
Editorial |
Diagnosis of moderate and high hypertriglyceridemia in patients in polyclinic practice: primary and secondary lipid metabolic disturbances |
|
卷 82, 编号 10 (2010) |
Editorial |
Methylglyoxal is a test for biological dysfunctions of homeostasis and endoecology, low cytosolic glucose level, and gluconeogenesis from fatty acids |
|
卷 83, 编号 8 (2011) |
Editorial |
Modern conceptions of an uric acid role in development of essential hypertension |
|
卷 83, 编号 9 (2011) |
Editorial |
Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale |
|
卷 84, 编号 9 (2012) |
Editorial |
Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events |
|
卷 85, 编号 9 (2013) |
Editorial |
Is there an association of uric acid level with preclinical target organ damage in moderate-and high-risk hypertensive patients? |
|
卷 86, 编号 9 (2014) |
Editorial |
Cystatin C and preclinical lesions in the target organs of hypertensive patients |
|
卷 87, 编号 9 (2015) |
Editorial |
Consecutive formation of the functions of high-, low-density and very-low-density lipoproteins during phylogenesis. Unique algorithm of the effects of lipid-lowering drugs |
|